Kumar Neil 4
4 · BridgeBio Pharma, Inc. · Filed Feb 18, 2026
Research Summary
AI-generated summary of this filing
BridgeBio (BBIO) CEO Neil Kumar Receives RSUs, 30,970 Shares Withheld
What Happened
Neil Kumar, CEO of BridgeBio Pharma (BBIO), had 64,698 restricted stock units (RSUs) vest on February 16, 2026. The RSUs converted into 64,698 shares of common stock; 30,970 of those shares were withheld to satisfy tax withholding obligations at $75.25 per share, equal to $2,330,493. The net result was issuance of approximately 33,728 shares to Kumar. This activity is vesting/award-related (not an open-market buy or voluntary sale).
Key Details
- Transaction date: 2026-02-16; Form 4 filed: 2026-02-18 (appears timely under Section 16 rules).
- Conversion (exercise of derivative/RSU) entries: 33,544 + 19,600 + 11,554 = 64,698 shares vested/converted.
- Tax withholding: 30,970 shares withheld (Code F) at $75.25/share = $2,330,493.
- Net shares issued to insider: ~33,728 shares (64,698 vested − 30,970 withheld).
- Shares owned after transaction: not specified in the report.
- Footnotes: RSUs represent contingent rights to common stock (F1); F2 confirms the withheld shares were to satisfy tax obligations; F4–F6 describe the RSU vesting schedule; F3 contains a standard beneficial ownership disclaimer.
- Transaction codes: M = exercise/conversion of a derivative (RSU conversion); F = shares withheld for tax withholding.
Context
- This was a standard RSU vesting and tax-withholding settlement (effectively a cashless settlement), not an open-market sale or purchase. Withholding of shares to cover taxes is common and does not necessarily indicate a change in insider sentiment.
- No 10b5-1 plan or late filing is indicated in the filing.
Insider Transaction Report
Form 4
Kumar Neil
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-02-16+33,544→ 262,320 total - Exercise/Conversion
Common Stock
[F1]2026-02-16+19,600→ 281,920 total - Exercise/Conversion
Common Stock
[F1]2026-02-16+11,554→ 293,474 total - Tax Payment
Common Stock
[F2]2026-02-16$75.25/sh−30,970$2,330,493→ 262,504 total - Exercise/Conversion
Restricted Stock Units
[F1][F4]2026-02-16−33,544→ 134,176 total→ Common Stock (33,544 underlying) - Exercise/Conversion
Restricted Stock Units
[F1][F5]2026-02-16−19,600→ 156,794 total→ Common Stock (19,600 underlying) - Exercise/Conversion
Restricted Stock Units
[F1][F6]2026-02-16−11,554→ 138,645 total→ Common Stock (11,554 underlying)
Holdings
- 675,686(indirect: By Trust)
Common Stock
[F3] - 4,478,447(indirect: By Trust)
Common Stock
[F3]
Footnotes (6)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 64,698 shares of Common Stock underlying the Reporting Person's RSUs.
- [F3]The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
- [F4]The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
- [F5]The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2024. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
- [F6]The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2025. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
Signature
/s/ Will Solis, Attorney-in-Fact|2026-02-18